ProfileGDS4718 / 218829_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 84% 80% 70% 79% 81% 86% 90% 80% 81% 82% 82% 78% 91% 90% 88% 84% 83% 92% 86% 88% 79% 81% 82% 82% 82% 92% 84% 94% 84% 90% 89% 87% 79% 84% 91% 84% 89% 82% 79% 71% 82% 91% 83% 93% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.3656284
GSM549102patient 115, normal, homogenized [OPG study]7.7339780
GSM549104patient 119, normal, homogenized [OPG study]6.9350470
GSM549108patient 138, normal, homogenized [OPG study]7.6900679
GSM549119patient 077, normal, homogenized [OPG study]7.9445481
GSM549133patient 032, cancer, homogenized [OPG study]8.7568986
GSM549139patient 042, cancer, homogenized [OPG study]9.1151890
GSM549099patient 107, normal, homogenized [OPG study]7.7902780
GSM549109patient 139, normal, homogenized [OPG study]7.9246481
GSM549110patient 046, normal, homogenized [OPG study]8.0442582
GSM549114patient 063, normal, homogenized [OPG study]8.2260982
GSM549122patient 082, normal, homogenized [OPG study]7.58978
GSM549134patient 033, cancer, homogenized [OPG study]9.3014191
GSM549136patient 036, cancer, homogenized [OPG study]9.2417490
GSM549140patient 044, cancer, homogenized [OPG study]8.9648288
GSM549111patient 047, normal, homogenized [OPG study]8.4165284
GSM549113patient 057, normal, homogenized [OPG study]8.3734883
GSM549132patient 031, cancer, homogenized [OPG study]9.5366292
GSM549137patient 038, cancer, homogenized [OPG study]8.6221886
GSM549142patient 047, cancer, homogenized [OPG study]8.4581588
GSM549100patient 110, normal, homogenized [OPG study]7.6717979
GSM549107patient 135, normal, homogenized [OPG study]8.0070981
GSM549115patient 068, normal, homogenized [OPG study]8.2841382
GSM549116patient 072, normal, homogenized [OPG study]8.1932482
GSM549120patient 078, normal, homogenized [OPG study]8.0865282
GSM549131patient 030, cancer, homogenized [OPG study]9.5837492
GSM549118patient 074, normal, homogenized [OPG study]8.3852184
GSM549129patient 027, cancer, homogenized [OPG study]9.7010594
GSM549123patient 088, normal, homogenized [OPG study]8.4054984
GSM549124patient 006, cancer, homogenized [OPG study]9.0105590
GSM549126patient 015, cancer, homogenized [OPG study]8.934889
GSM549128patient 025, cancer, homogenized [OPG study]8.8217887
GSM549103patient 117, normal, homogenized [OPG study]7.6647879
GSM549117patient 073, normal, homogenized [OPG study]8.4822784
GSM549138patient 041, cancer, homogenized [OPG study]9.3651791
GSM549141patient 045, cancer, homogenized [OPG study]8.4126484
GSM549130patient 028, cancer, homogenized [OPG study]8.9094389
GSM549101patient 111, normal, homogenized [OPG study]8.0843582
GSM549105patient 128, normal, homogenized [OPG study]7.6964879
GSM549106patient 134, normal, homogenized [OPG study]7.0549871
GSM549112patient 048, normal, homogenized [OPG study]8.1401282
GSM549125patient 011, cancer, homogenized [OPG study]9.228791
GSM549127patient 024, cancer, homogenized [OPG study]8.1717383
GSM549135patient 035, cancer, homogenized [OPG study]9.8286293